[go: up one dir, main page]

ITMI921930A1 - Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda - Google Patents

Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda

Info

Publication number
ITMI921930A1
ITMI921930A1 IT001930A ITMI921930A ITMI921930A1 IT MI921930 A1 ITMI921930 A1 IT MI921930A1 IT 001930 A IT001930 A IT 001930A IT MI921930 A ITMI921930 A IT MI921930A IT MI921930 A1 ITMI921930 A1 IT MI921930A1
Authority
IT
Italy
Prior art keywords
dihydropyridins
drink
pharmaceutical compositions
oral administration
oral
Prior art date
Application number
IT001930A
Other languages
English (en)
Inventor
Silvana Ciceri
Gilberto Dondi
Paolo Scurati
Original Assignee
Bayer Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Italia Spa filed Critical Bayer Italia Spa
Priority to ITMI921930A priority Critical patent/IT1255792B/it
Publication of ITMI921930A0 publication Critical patent/ITMI921930A0/it
Priority to EP93111920A priority patent/EP0582169A3/de
Priority to US08/099,288 priority patent/US5491154A/en
Priority to CA002101680A priority patent/CA2101680A1/en
Priority to JP5209968A priority patent/JPH072700A/ja
Publication of ITMI921930A1 publication Critical patent/ITMI921930A1/it
Priority to US08/536,552 priority patent/US5622978A/en
Application granted granted Critical
Publication of IT1255792B publication Critical patent/IT1255792B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • A61K31/787Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79Polymers of vinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ITMI921930A 1992-08-05 1992-08-05 Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda IT1255792B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ITMI921930A IT1255792B (it) 1992-08-05 1992-08-05 Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda
EP93111920A EP0582169A3 (en) 1992-08-05 1993-07-26 Pharmaceutical preparations for the oral administration of dihydropyridines in beverage form
US08/099,288 US5491154A (en) 1992-08-05 1993-07-29 Pharmaceutical preparation for the oral administration of dihydropyridines
CA002101680A CA2101680A1 (en) 1992-08-05 1993-07-30 Pharmaceutical preparations for the oral administration of dihydropyridines in beverage form
JP5209968A JPH072700A (ja) 1992-08-05 1993-08-03 ジヒドロピリジンの飲料の形態の経口投与用製薬学的組成物
US08/536,552 US5622978A (en) 1992-08-05 1995-09-29 Pharmaceutical preparations for the oral administration of dihydropyridines in beverage form

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI921930A IT1255792B (it) 1992-08-05 1992-08-05 Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda

Publications (3)

Publication Number Publication Date
ITMI921930A0 ITMI921930A0 (it) 1992-08-05
ITMI921930A1 true ITMI921930A1 (it) 1994-02-05
IT1255792B IT1255792B (it) 1995-11-16

Family

ID=11363839

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI921930A IT1255792B (it) 1992-08-05 1992-08-05 Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda

Country Status (5)

Country Link
US (2) US5491154A (it)
EP (1) EP0582169A3 (it)
JP (1) JPH072700A (it)
CA (1) CA2101680A1 (it)
IT (1) IT1255792B (it)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
EP0859603B1 (en) 1996-07-08 2008-12-17 Penwest Pharmaceuticals Co. Sustained release matrix for high-dose insoluble drugs
US5891469A (en) * 1997-04-02 1999-04-06 Pharmos Corporation Solid Coprecipitates for enhanced bioavailability of lipophilic substances
WO1998008490A1 (en) * 1996-09-01 1998-03-05 Pharmos Corporation Solid coprecipitates for enhanced bioavailability of lipophilic substances
US5989463A (en) 1997-09-24 1999-11-23 Alkermes Controlled Therapeutics, Inc. Methods for fabricating polymer-based controlled release devices
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
GB9920558D0 (en) * 1999-08-31 1999-11-03 Bradford Particle Design Ltd Methods for particle formation and their products
MXPA01005370A (es) 1999-09-30 2004-05-14 Penwest Pharmaceuticals Co Sistema de matriz de liberacion sostenida para farmacos altamente solubles.
IL134701A0 (en) * 2000-02-23 2001-04-30 J P M E D Ltd Homogeneous solid matrix containing vegetable proteins
US6589955B2 (en) 2001-06-20 2003-07-08 Bristol-Myers Squibb Company Pediatric formulation of gatifloxacin
EP1401399A2 (en) * 2001-06-22 2004-03-31 Pfizer Products Inc. Pharmaceutical compositions containing polymer and drug assemblies
US20040185110A1 (en) * 2002-11-08 2004-09-23 Ronald Harland Formulations of low solubility bioactive agents and processes for making the same
BRPI0412190A (pt) * 2003-07-01 2006-08-22 Pharmacia & Upjohn Co Llc sólidos com camada de difusão modulada
US7507823B2 (en) * 2004-05-06 2009-03-24 Bristol-Myers Squibb Company Process of making aripiprazole particles
TR201100152A2 (tr) * 2011-01-06 2012-07-23 Bi̇lgi̇ç Mahmut Amlodipin içeren efervesan bileşimler.
US9399019B2 (en) 2012-05-09 2016-07-26 Evonik Corporation Polymorph compositions, methods of making, and uses thereof
CN105596293A (zh) * 2016-01-29 2016-05-25 中国药科大学 一种脑靶向尼莫地平纳米混悬剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
DE1962791A1 (de) * 1969-12-15 1971-06-24 Boehringer Mannheim Gmbh Brausetabletten,Brausepulver und Verfahren zur Herstellung derselben
US4154839A (en) * 1975-11-05 1979-05-15 Bayer Aktiengesellschaft 2,6-Dimethyl-3-carboxymethoxy-4-(2-nitrophenyl)-5-carbisobutoxy-1,4-dihydropyridine
EP0001247A1 (en) * 1977-09-14 1979-04-04 Kanebo, Ltd. Pharmaceutical preparation containing nifedipine and a method for producing the same.
DE2815578C2 (de) * 1978-04-11 1986-01-16 Bayer Ag, 5090 Leverkusen Neue pharmazeutische Verwendung von Nimodipin
JPH0729926B2 (ja) * 1989-07-25 1995-04-05 大塚製薬株式会社 易吸収性製剤用組成物
GB9025251D0 (en) * 1990-11-20 1991-01-02 Solomon Montague C Nifedipine dosage forms

Also Published As

Publication number Publication date
ITMI921930A0 (it) 1992-08-05
US5491154A (en) 1996-02-13
CA2101680A1 (en) 1994-02-06
IT1255792B (it) 1995-11-16
JPH072700A (ja) 1995-01-06
US5622978A (en) 1997-04-22
EP0582169A2 (de) 1994-02-09
EP0582169A3 (en) 1995-09-27

Similar Documents

Publication Publication Date Title
ITMI921930A1 (it) Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda
ITMI911149A0 (it) Composizioni farmaceutiche in forma di schiuma per somministrazione intravaginale, cutanea e orale
NO943761L (no) Oralt administrerbare opioide formuleringer med forlenget effektvarighet
ITBO910024A0 (it) Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale
IT1177152B (it) Procedimento e composizione per la preparazione di prodotti farmaceutici ad azione prolungata controllata per la somministrazione orale
IT1184653B (it) Preparato a forma di foglio per la somministrazione di prodotti nella cavita' orale
IL115097A0 (en) Pharmaceutical compositions adapted for oral administration
ATE219377T1 (de) Neue galenische orale pharmazeutische formulierung
DE4291156T1 (de) Verbesserte pharmazeutische Zusammensetzungen
FI950947L (fi) Oraalisesti annettavat farmaseuttiset formulaatiot
EP0652770A4 (en) ORAL GIVING OF ANTIGENS.
ITMI930605A1 (it) Formulazioni orali di ubidecarenone in forma di capsule
FI910088A7 (fi) Oraalinen farmaseuttinen koostumus
NO950134D0 (no) Formuleringer for oralt administrerte farmasöytiske midler
ITTO920303A0 (it) "composizione farmaceutica antiinfiammatoria"
IT9019112A1 (it) Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
MX9203615A (es) Composicion farmaceutica en forma de polvo para administracion nasal.
IT1234194B (it) Composizioni farmaceutiche in forma di sciroppo contenenti pentitoli quali agenti di veicolazione
IT9021021A0 (it) Composizioni farmaceutiche per la somministrazione orale di irudina
FI952377A7 (fi) Farmaseuttisia ibuprofeenikoostumuksia
ITMI911445A1 (it) Impiego di derivati fosfolipidici per la preparazione di composizioni farmaceutiche aventi attivita' immunosoppressiva
FI934387A7 (fi) 3-substituoituja 2-oksi-indoli-1-karboksiamidia käsittäviä farmaseuttisia koostumuksia
ITMI913510A1 (it) Composizioni farmaceutiche contenenti progesterone ad elevata biodisponibilita'
IT8219012A0 (it) Metodo per la somministrazione orale di sostanze sotto forma di liposomi, e relative formulazioni farmaceutiche.
ITRM920535A0 (it) Composizione farmaceutica per la somministrazione attraverso le mucose.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970827